Global Biopharmaceuticals Market By Type Overview
Introduction:
Biopharmaceuticals Market was valued at US$ 322.7 Billion in 2024 and is projected to grow at a CAGR of 8.9% to reach US$ 703.3 Billion by 2034.
Biopharmaceutical is the pharmaceutical medical drugs which are produced by the biotechnological methods. The biotechnological methods involve hybridoma technology, fermentation, DNA isolation & recombinant DNA technology, and purification processes. Biopharmaceuticals are the complex and large molecular drug produced by using living organisms which has high- therapeutic value.
Biopharmaceutical offers highly effective and disease specific therapy which is the major propelling factor for the growth of the global market. In addition, the biopharmaceuticals have fewer side effects than the pharmaceutical which is another driving factor for the growth of target market. Moreover, biopharmaceutical has actual potential to cure diseases that increase the demand of biopharmaceutical among the population which is the boosting factor for the growth of global market. However, the cost of producing biopharmaceutical is high which is the restraining factor for the growth of the target market.
The biopharmaceuticals market is segmented based on type, application, and region. On the basis of type, the global biopharmaceuticals market is classified into monoclonal antibody, recombinant growth factors, purified proteins, recombinant proteins, recombinant hormones, vaccines, and synthetic immunomodulatory. Based on application, the global market is bifurcated into oncology, inflammatory & infectious diseases, autoimmune disorders, metabolic disorders, and others (hormonal disorders, diseases prevention, cardiovascular diseases, and neurological diseases).
On the basis of region, the biopharmaceuticals market is categorized into North America, Europe, Asian Pacific, Latin America, and Middle East & Africa. North America market dominates the global market in terms of revenue over the forecast period. This can be attributed to the high rate of adoption of the advanced technologies in the market studied. Presence of key players such as Pfizer Inc., in the target market is also major factor for the growth of this region.
The key players operating the Biopharmaceuticals market involves Pfizer Inc., Biogen, Inc., Abbott Laboratories, Amgen, Inc., Novo Nordisk A/S, Eli Lilly and Company, F. Hoffmann-La Roche, Ltd., Johnson & Johnson, Merck & Co., Inc., and Sanofi. Prominent players operating in the target market are focusing on the strategic partnerships as well as launching of the products in order to gain competitive edge in the target market.
Detailed Segmentation:
Biopharmaceuticals Market, By Type:
- Monoclonal Antibody
- Recombinant Growth Factors
- Purified Proteins
- Recombinant Proteins
- Recombinant Hormones
- Vaccines
- Synthetic Immunomodulatory
Biopharmaceuticals Market, By Application:
- Oncology
- Inflammatory & Infectious Diseases
- Autoimmune Disorders
- Metabolic Disorders
- Others (Hormonal Disorders, Diseases Prevention, Cardiovascular Diseases, and Neurological Diseases)
Biopharmaceuticals Market, By Region:
- North America
- Middle East & Africa
- Middle East & Africa Biopharmaceuticals Market, By Type
- Middle East & Africa Biopharmaceuticals Market, By Application
- Middle East & Africa Biopharmaceuticals Market, By Country
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Latin America Biopharmaceuticals Market, By Type
- Latin America Biopharmaceuticals Market, By Application
- Latin America Biopharmaceuticals Market, By Country
- Brazil
- Mexico
- Rest of Latin America
- Asia Pacific
- Asia Pacific Biopharmaceuticals Market, By Type
- Asia Pacific Biopharmaceuticals Market, By Application
- Asia Pacific Biopharmaceuticals Market, By Country
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Europe
- Europe Biopharmaceuticals Market, By Type
- Europe Biopharmaceuticals Market, By Application
- Europe Biopharmaceuticals Market, By Country
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- North America Biopharmaceuticals Market, By Type
- North America Biopharmaceuticals Market, By Application
- North America Biopharmaceuticals Market, By Country
- U.S.
- Canada
- Middle East & Africa
Company Profile:
- Pfizer Inc.*
- Company Overview
- Type Portfolio
- Key Highlights
- Financial Performance
- Biogen, Inc.
- Abbott Laboratories
- Amgen, Inc.
- Novo Nordisk A/S
- Eli Lilly and Company
- F. Hoffmann-La Roche, Ltd.
- Johnson & Johnson
- Merck & Co. Inc.
- Sanofi SA
“*” marked represents similar segmentation in other categories in the respective section
Global Biopharmaceuticals Market By Type Table of Contents
Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Type
- Market Snippet, By Application
- Market Snippet, By Region
- Opportunity Map Analysis
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Global Biopharmaceuticals Market, By Type, 2019 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 — 2029
- Y-o-Y Growth Analysis (%), 2019 – 2029
- Segment Trends
- Monoclonal Antibody
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Recombinant Growth Factors
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Purified Proteins
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Recombinant Proteins
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Recombinant Hormones
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Vaccines
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Synthetic Immunomodulatory
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Overview
- Global Biopharmaceuticals Market, By Application, 2019 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 — 2029
- Y-o-Y Growth Analysis (%), 2019 – 2029
- Segment Trends
- Oncology
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Inflammatory & Infectious Diseases
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Autoimmune Disorders
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Metabolic Disorders
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Others (Hormonal Disorders, Diseases Prevention, Cardiovascular Diseases, and Neurological Diseases)
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Overview
- Global Biopharmaceuticals Market, By Region, 2019 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 — 2029
- Y-o-Y Growth Analysis (%), 2019 – 2029
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Type, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Type, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Type, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Type, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Type, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
-
- Pfizer, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Biogen, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Abbott Laboratories
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Amgen, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Novo Nordisk A/S
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Eli Lilly and Company
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- F. Hoffmann-La Roche Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Johnson & Johnson
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Merck & Co. Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Sanofi
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Pfizer, Inc.
-
- Section
- Research Methodology
- About Us
- Contact
FAQs
the development of biosimilars and biobetters, the growth of targeted therapies, and advancements in bioprocessing technologies, presenting significant opportunities in the global Biopharmaceuticals Market.
increasing demand for personalized medicine, advancements in biotechnology and molecular biology, the rise of monoclonal antibody therapies, and the expansion of biopharmaceutical manufacturing capacities.
North America and Europe are expected to dominate the Biopharmaceuticals Market, driven by established biotechnology and pharmaceutical industries, a strong regulatory framework, and significant research and development activities in these regions.
The key players operating the global Biopharmaceuticals market involves Pfizer Inc., Biogen, Inc., Abbott Laboratories, Amgen, Inc., Novo Nordisk A/S, Eli Lilly and Company, F. Hoffmann-La Roche, Ltd., Johnson & Johnson, Merck & Co., Inc., and Sanofi. Prominent players operating in the target market are focusing on the strategic partnerships as well as launching of the products in order to gain competitive edge in the target market.